News | Cardiovascular Ultrasound | August 05, 2019

Digital Health Devices Used at Point of Care May Improve Diagnostic Certainty

Rural medical outreach event compared conventional clinical assessment with technology-first assessments including smartphone-enabled pocket ultrasound

Digital Health Devices Used at Point of Care May Improve Diagnostic Certainty

August 5, 2019 — A West Virginia-based rural medical outreach event showcased the use of point-of-care technology in an ambulatory setting and demonstrated that it can enhance clinical decision making. Physicians used new digital health technologies to diagnose acute and chronic cardiovascular diseases in a resource-limited area, and found that it improved their ability to diagnose common cardiac conditions such as atrial fibrillation and heart failure. Research findings on how this technology-based care impacts provider referral and downstream testing were presented during the 30th Annual American Society of Echocardiography (ASE) Scientific Sessions, June 21-25 in Portland, Ore.

The study compared conventional clinical assessment with technology-first assessments used as clinical decision-support tools to understand the incremental value of digital health devices in clinical diagnoses, referrals, resource utilization and perceived quality of care. Patients were randomly assigned to either standard care or to digital health assessments. Psychological well-being, lifestyles and habits, risk factors, and user experiences were measured using onsite and follow-up surveys. In the technology arm, point-of-care tests included smartphone-enabled pocket ultrasound and electrocardiogram, and wireless vital sign devices were provided at the patient visit. 

Presenting author Sirish Shrestha, M.Sc., biostatistician and machine learning research scientist, said, “It was an exhilarating experience where 374 patients had over 1,000 point-of-care tests performed within six hours with engineers, providers, sonographers and many industry partners coming together for a wonderful cause." 

Partho Sengupta, M.D., FASE, senior author added, “This study builds upon our previous experiences in ASE Foundation outreach events and bringing back to the United States what we learned abroad.” 

Listen to the PODCAST: How Technology Is Changing Cardiology, an interview with Sengupta

For more information:

Related Content

ASNC Announces Multisocietal Cardiac Amyloidosis Imaging Consensus
News | Cardiac Imaging | September 09, 2019
September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along
Medical Imaging Rates Continue to Rise Despite Push to Reduce Their Use
News | Radiology Imaging | September 03, 2019
Despite a broad campaign among physician groups to reduce the amount of medical imaging, use rates of various scans...
Philips Debuts Cardiac Ultrasound and Enterprise Informatics Offerings at ESC 2019
News | Cardiac Imaging | August 30, 2019
Philips will showcase its latest cardiac care innovations at the European Society of Cardiology (ESC) Congress 2019,...
CIRS Launches Ultrasound Quality Assurance Software
Technology | Quality Assurance (QA) | August 30, 2019
August 30, 2019 — The CIRS Ultrasound...
Terason Partners With DiA Imaging Analysis for Point-of-care Cardiac Ultrasound AI
News | Cardiovascular Ultrasound | August 26, 2019
Ultrasound imaging company Terason has partnered with DiA Imaging Analysis, provider of artificial intelligence (AI)-...
Exo Imaging Raises $35 Million for Developmental Ultrasound Platform
News | Ultrasound Imaging | August 23, 2019
Exo Imaging Inc. announced a $35 million Series B financing round for its high-performance ultrasound platform based on...
Improved Imaging Technique Could Increase Chances of Prostate Cancer Survival
News | Prostate Cancer | August 20, 2019
According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their...
Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro
Technology | Interventional Radiology | August 16, 2019
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
Contrast Use in First Transthoracic Echocardiogram for Heart Failure Reduces Repeat Testing
News | Cardiovascular Ultrasound | August 07, 2019
Heart failure is the fourth most common cause for all admission to U.S. hospitals, and it is the most common reason for...